People · Operator

Andrew Rasdal

Named in public records as an officer, director or promoter · active 2012–2018 · Biotechnology

1
Companies
5
Filings
$48.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Obalon Therapeutics IncBiotechnologySeries B$48.9M$396.9M2012
Operator network

Andrew Rasdal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kim Puloma Kamdar · 2 companies · 1 sharedKim Puloma KamdarDavid J. Moatazedi · 1 companies · 1 sharedDavid J. MoatazediDouglas C. Puloma Sampson · 1 companies · 1 sharedDouglas C. Puloma…Douglas J. Fisher · 1 companies · 1 sharedDouglas J. FisherDoug Puloma Fisher · 1 companies · 1 sharedDoug Puloma FisherKelly J. Huang, Ph.D. · 1 companies · 1 sharedKelly J. Huang, P…Kim J. Kamdar, Ph.D. · 1 companies · 1 sharedKim J. Kamdar, Ph…Les J. Howe · 1 companies · 1 sharedLes J. HoweMark J. Brister · 1 companies · 1 sharedMark J. BristerRaymond J. Dittamore · 1 companies · 1 sharedRaymond J. Dittam…Sharon J. Stevenson, DVM Ph.D. · 1 companies · 1 sharedSharon J. Stevens…Sharon Puloma Stevenson · 1 companies · 1 sharedSharon Puloma Ste…William J. Plovanic · 1 companies · 1 sharedWilliam J. Plovan…Obalon Therapeutics Inc · $48.9M raisedObalon Therapeutics I…Andrew RasdalAR
Andrew Rasdal Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Andrew Rasdal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kim Puloma Kamdar12
Douglas C. Puloma Sampson11
Sharon Puloma Stevenson11
Doug Puloma Fisher11
Les J. Howe11
Mark J. Brister11
Kelly J. Huang, Ph.D.11
Douglas J. Fisher11
David J. Moatazedi11
Raymond J. Dittamore11
Sharon J. Stevenson, DVM Ph.D.11
Kim J. Kamdar, Ph.D.11
William J. Plovanic11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.